The primary antibodies included -actin (Sigma-Aldrich, A5316), lamin B1 (HUABIO Antibodies, ET1606-27), HIF-1 (Abcam, ab228649), HIF-2 (Novus, NB100-122), Acer2 (PA5-39016), PP2A (Invitrogen, MA5-32920), p-PP2A (Invitrogen, MA5-32158), -syn (BD, 8249518), and p--syn (Abcam, ab51253)
IGF-1 activates the Akt pathway, which is a downstream activator of mTOR, both of which are the master regulators of cellular growth and inhibitors of programmed cell death in the body
Minimizing injection site reactions involves several strategies
Appetite suppression to excess some users report feeling too full , which can lead to reduced nutrient intake
The only human data available comes from a 2025 pilot study by Lee and Burgess, published in Alternative Therapies in Health and Medicine